
Anthropic and OpenAI each launched a separately capitalized deployment vehicle in the same news cycle Monday — Anthropic's $1.5B JV with Blackstone, Goldman Sachs, and Hellman & Friedman to push Claude into mid-market enterprises, and OpenAI's $4B+ raise at a $10B pre-money for a new venture called The Deployment Company. Cerebras filed updated IPO terms with a $115–$125 range and a $26.6B fully-diluted mark, and Anthropic's separate $50B primary round at a $900B valuation could close within two weeks.
Anthropic and OpenAI launched parallel deployment vehicles on Monday. Anthropic announced a $1.5B joint venture with Blackstone, Hellman & Friedman, and Goldman Sachs — Blackstone and H&F each reportedly committing ~$300M, Goldman ~$150M, with General Atlantic, Leonard Green, Apollo, GIC, and Sequoia following on — to embed Claude inside mid-size businesses, with healthcare, manufacturing, financial services, and real estate as initial sectors. Same news cycle, Bloomberg reported that OpenAI has finalized a $10B post-money JV called The Deployment Company, anchored by TPG and Brookfield (with Advent, Bain, and Goanna among 19 investors), pulling in $4B+ of fresh PE capital. OpenAI commits up to $1.5B itself, reportedly retains super-voting control, and reportedly offers PE backers a guaranteed 17.5% minimum return and payment seniority, per The Next Web's read of the structure. TechCrunch covers both side-by-side.
The structural read is the lead. The bottleneck on AI enterprise revenue is no longer the lab's ability to ship a model — it's the slow industrial work of getting an agent embedded next to a knowledge worker. Both vehicles say so explicitly: anchored by PE firms that historically wanted nothing to do with frontier-lab equity, with structural protections (Anthropic's targeted-deal cohort; OpenAI's guaranteed-return floor) that look more like infrastructure underwriting than venture pricing.
Three things follow for private markets readers. The buyer pool has shifted: Blackstone, H&F, TPG, and Brookfield underwrite contracted services revenue and infrastructure-style cash flow, and the JV structure is what makes the AI value chain digestible for them. This is a new pre-IPO security category — the OpenAI Deployment Company is a $14B post-money instrument distinct from OpenAI parent's $852B March mark, and may begin to trade on Forge or Hiive in its own right over the coming quarters. And it's a structural admission. By agreeing on day one to share both the customer relationship and the upside with a third-party vehicle, the labs have positioned the model itself as closer to a supplier than a brand.

Cerebras filed an amended S-1 Monday with a $115–$125 price range across 28 million shares — a $3.5B raise at a $26.6B fully-diluted valuation, with pricing teed up for the night of May 13 and first trades May 14 on the Nasdaq under CBRS (SiliconANGLE). Morgan Stanley, Citi, Barclays, and UBS lead the book.
The number worth flagging isn't $26.6B in isolation. It's where it sits relative to the secondary tape. Forge and Hiive desks were quoting Cerebras at $26–28B through April, against the original April 17 S-1 target of $22–25B. Monday's filing didn't move toward the secondary mark — it landed inside it. That's a setup we haven't seen often this cycle. For most of the last decade, IPOs priced through the secondary market and private holders took a haircut on the way out. Cerebras reverses the polarity: the secondary tape was the leading indicator, and the IPO is being marked to it. Two reads. This is a confirmed-bid event, not a price-discovery event — exactly what the IPO market needs after eight quarters of cancellations. And whatever clears May 13 becomes the comp the rest of the AI infra cohort has been waiting for: Groq, SambaNova, Tenstorrent, Etched.
The thing the IPO investor is really being asked to underwrite isn't Cerebras' chip economics. It's the $20B+ Master Relationship Agreement with OpenAI— a 750 MW compute commit through 2030 with an option to scale to 2 GW, plus warrants that could give OpenAI up to ~10% of Cerebras at full vesting. Strip the MRA out and the trailing-twelve-month picture is $510M in FY25 revenue chasing a $26.6B mark.

The post-money valuation of OpenAI's new "Deployment Company" JV — $4B+ in fresh capital at a $10B pre-money mark, per Bloomberg's reportingMonday. Anthropic's parallel JV with Blackstone, H&F, and Goldman is $1.5B in committed capital. Together that's $5.5B+ of fresh institutional money committed in a single news cycle to a structure that didn't exist a quarter ago — a frontier-lab deployment vehicle, separately capitalized, with PE-style backers underwriting services revenue rather than model risk. If the OpenAI Deployment Company begins to trade on the secondary platforms over the coming quarters, the marks will be the first read on whether the market thinks the deployment business deserves a multiple of its own — distinct from the lab parent.
A provision in an IPO that gives the underwriters the right to sell additional shares — typically up to 15% — at the offering price, usually within 30 days, if demand exceeds the base allocation. Named after Green Shoe Manufacturing, where the structure first appeared in 1963. In Cerebras' filing Monday, the syndicate holds an option on an additional 4.2 million shares on top of the 28 million-share base, which at the top of the range would push the total raise from ~$3.5B to closer to $3.9B. The greenshoe is the cleanest single signal of how oversubscribed an IPO actually was — if it gets exercised in full within the first month, demand was real, not staged.